Nanogen, Affymetrix, Definiens, Ontario Government, Lakehead University, Gentana, Monsanto, Li-Cor Biosciences, Biolog | GenomeWeb

Nanogen Shares Spike Up on European Patent News

Shares in Nanogen closed up Monday 22.28 percent, or $.88, in heavy-volume trade after the company said its SynX subsidiary had won a European patent.

The stock closed at $4.83 on the Nasdaq exchange as almost 6 million shares traded hands — compared to the average share volume of 636,863 for the past three months. The shares receded somewhat on Tuesday afternoon, falling 7.5 percent, or $.36, to $4.47.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.